A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

NCT02939807 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study is being rewritten for different disease population

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: ABC294640

Sponsor

Medical University of South Carolina

Collaborators

[object Object]
[object Object]